Stentys Reports 2016 First-Half Results
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News:
STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces its half-year results to June 30, 2016, as approved by the Board meeting of September 15, 2016.
STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces its half-year results to June 30, 2016, as approved by the Board meeting of September 15, 2016.